Keywords: fda, priority, review, viropharma, cinryze, food, drug

FDA priority review for ViroPharma's Cinryze

Article | 09 February 2009

Print This

The US Food and Drug Administration has granted priority review for ViroPharma's Cinryze C1 inhibitor (human) as a treatment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in